(Q38933111)

7 September 2017

title

Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β. (English)

1 reference

7 September 2017

0 references

Jennifer R Gatchel

11

0 references

Bernard J Hanseeuw

object named as

Bernard J Hanseeuw

12

0 references

Aaron P. Schultz

object named as

Aaron P Schultz

13

0 references

Paul S. Aisen

14

object named as

Paul S Aisen

1 reference

7 September 2017

5

Rebecca Amariglio

1 reference

7 September 2017

Elizabeth C Mormino

1

1 reference

7 September 2017

Kathryn V Papp

2

1 reference

7 September 2017

Dorene M Rentz

3

1 reference

7 September 2017

Michael C Donohue

4

1 reference

7 September 2017

Yakeel T Quiroz

6

1 reference

7 September 2017

Jasmeer Chhatwal

7

1 reference

7 September 2017

Gad A Marshall

8

1 reference

7 September 2017

Nancy Donovan

9

1 reference

7 September 2017

Jonathan Jackson

10

1 reference

7 September 2017

Keith A Johnson

15

1 reference

7 September 2017

Reisa A Sperling

16

1 reference

7 September 2017

publication date

27 February 2017

1 reference

7 September 2017

published in

Alzheimer's and Dementia

1 reference

7 September 2017

volume

13

1 reference

7 September 2017

issue

9

1 reference

7 September 2017

page(s)

1004-1012

1 reference

Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia.

7 September 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Biomarker validation of a decline in semantic processing in preclinical Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Tau positron emission tomographic imaging in aging and early Alzheimer disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

CAP--advancing the evaluation of preclinical Alzheimer disease treatments

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The A4 study: stopping AD before symptoms begin?

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Regulatory innovation and drug development for early-stage Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Screening for predementia AD: time-dependent operating characteristics of episodic memory tests

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Neuropsychological prediction of decline to dementia in nondemented elderly

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

Free and cued selective reminding and selective reminding in the elderly.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The Clinical Dementia Rating (CDR): current version and scoring rules

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

The Modified Mini-Mental State (3MS) examination

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5573651

10.1016/J.JALZ.2017.01.018

31 August 2018

Identifiers

DOI

1 reference

7 September 2017

0 references

1 reference